Rights granted for reproduction by any legitimate news organization. However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. Information is believed accurate, as provided by news source or authorized agency, however is not guaranteed, and you assume all risk for use of any information found herein/hereupon. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
Local Reads as of 2017-11-24 08:06:09: 1,266 views
REFERENCES:Business News, 8th Annual BIO Investor Forum, Epeius Biotechnologies, Rexin-G, a tumor-targeted anti-cancer agent that is approved for use against all solid tumors, Frederick L. Hall, Dr. Erlinda M. Gordon, therapeutic innovation, investing and banking in the life sciences industry Epeius Biotechnologies Corporation